169 related articles for article (PubMed ID: 33762591)
1. Morphofunctional analysis of human pancreatic cancer cell lines in 2- and 3-dimensional cultures.
Minami F; Sasaki N; Shichi Y; Gomi F; Michishita M; Ohkusu-Tsukada K; Toyoda M; Takahashi K; Ishiwata T
Sci Rep; 2021 Mar; 11(1):6775. PubMed ID: 33762591
[TBL] [Abstract][Full Text] [Related]
2. Enhanced morphological and functional differences of pancreatic cancer with epithelial or mesenchymal characteristics in 3D culture.
Shichi Y; Sasaki N; Michishita M; Hasegawa F; Matsuda Y; Arai T; Gomi F; Aida J; Takubo K; Toyoda M; Yoshimura H; Takahashi K; Ishiwata T
Sci Rep; 2019 Jul; 9(1):10871. PubMed ID: 31350453
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma: Characterization in a 3D-cell culture model.
Gagliano N; Celesti G; Tacchini L; Pluchino S; Sforza C; Rasile M; Valerio V; Laghi L; Conte V; Procacci P
World J Gastroenterol; 2016 May; 22(18):4466-83. PubMed ID: 27182158
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the metastatic potential of the floating cell component of MIA PaCa-2, a human pancreatic cancer cell line.
Sasaki N; Gomi F; Hasegawa F; Hirano K; Fujiwara M; Toyoda M; Ishiwata T
Biochem Biophys Res Commun; 2020 Feb; 522(4):881-888. PubMed ID: 31806369
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence-based analysis of time-lapse images of sphere formation and process of plate adhesion and spread of pancreatic cancer cells.
Shichi Y; Gomi F; Hasegawa Y; Nonaka K; Shinji S; Takahashi K; Ishiwata T
Front Cell Dev Biol; 2023; 11():1290753. PubMed ID: 38046666
[No Abstract] [Full Text] [Related]
6. Morphological and cytoskeletal changes of pancreatic cancer cells in three-dimensional spheroidal culture.
Matsuda Y; Ishiwata T; Kawamoto Y; Kawahara K; Peng WX; Yamamoto T; Naito Z
Med Mol Morphol; 2010 Dec; 43(4):211-7. PubMed ID: 21267697
[TBL] [Abstract][Full Text] [Related]
7. Grainyhead-like 2 (GRHL2) regulates epithelial plasticity in pancreatic cancer progression.
Nishino H; Takano S; Yoshitomi H; Suzuki K; Kagawa S; Shimazaki R; Shimizu H; Furukawa K; Miyazaki M; Ohtsuka M
Cancer Med; 2017 Nov; 6(11):2686-2696. PubMed ID: 28960866
[TBL] [Abstract][Full Text] [Related]
8. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment.
Wong CW; Han HW; Tien YW; Hsu SH
Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644
[TBL] [Abstract][Full Text] [Related]
9. Epithelial and Mesenchymal Features of Pancreatic Ductal Adenocarcinoma Cell Lines in Two- and Three-Dimensional Cultures.
Shichi Y; Gomi F; Sasaki N; Nonaka K; Arai T; Ishiwata T
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629168
[TBL] [Abstract][Full Text] [Related]
10. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
[TBL] [Abstract][Full Text] [Related]
11. Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers.
Sasaki N; Toyoda M; Hasegawa F; Fujiwara M; Gomi F; Ishiwata T
Biochem Biophys Res Commun; 2019 Jun; 514(1):112-117. PubMed ID: 31027735
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.
Momeny M; Alishahi Z; Eyvani H; Esmaeili F; Zaghal A; Ghaffari P; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Cell Oncol (Dordr); 2020 Feb; 43(1):81-93. PubMed ID: 31512195
[TBL] [Abstract][Full Text] [Related]
13. Stemness and anti-cancer drug resistance in ATP-binding cassette subfamily G member 2 highly expressed pancreatic cancer is induced in 3D culture conditions.
Sasaki N; Ishiwata T; Hasegawa F; Michishita M; Kawai H; Matsuda Y; Arai T; Ishikawa N; Aida J; Takubo K; Toyoda M
Cancer Sci; 2018 Apr; 109(4):1135-1146. PubMed ID: 29444383
[TBL] [Abstract][Full Text] [Related]
14. Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles.
Tidwell TR; Røsland G; Tronstad KJ; Søreide K; Hagland HR
Cancer Med; 2024 Jun; 13(11):e7318. PubMed ID: 38872378
[TBL] [Abstract][Full Text] [Related]
15. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
16. Multiple cystic sphere formation from PK-8 cells in three-dimensional culture.
Shichi Y; Gomi F; Ueda Y; Nonaka K; Hasegawa F; Hasegawa Y; Hinata N; Yoshimura H; Yamamoto M; Takahashi K; Arai T; Ishiwata T
Biochem Biophys Rep; 2022 Dec; 32():101339. PubMed ID: 36105614
[TBL] [Abstract][Full Text] [Related]
17. Cellular context-dependent interaction between cancer and stellate cells in hetero-type multicellular spheroids of pancreatic tumor.
Nam S; Khawar IA; Park JK; Chang S; Kuh HJ
Biochem Biophys Res Commun; 2019 Jul; 515(1):183-189. PubMed ID: 31133378
[TBL] [Abstract][Full Text] [Related]
18. Biphenotypic Differentiation of Pancreatic Cancer in 3-Dimensional Culture.
Matsushita Y; Smith B; Delannoy M; Trujillo MA; Chianchiano P; McMillan R; Kamiyama H; Liang H; Thompson ED; Hruban RH; Matsui W; Wood LD; Roberts NJ; Eshleman JR
Pancreas; 2019 Oct; 48(9):1225-1231. PubMed ID: 31593010
[TBL] [Abstract][Full Text] [Related]
19. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing.
Longati P; Jia X; Eimer J; Wagman A; Witt MR; Rehnmark S; Verbeke C; Toftgård R; Löhr M; Heuchel RL
BMC Cancer; 2013 Feb; 13():95. PubMed ID: 23446043
[TBL] [Abstract][Full Text] [Related]
20. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.
Novák Š; Kolář M; Szabó A; Vernerová Z; Lacina L; Strnad H; Šáchová J; Hradilová M; Havránek J; Španko M; Čoma M; Urban L; Kaňuchová M; Melegová N; Gürlich R; Dvořák J; Smetana K; Gál P; Szabo P
Cancer Genomics Proteomics; 2021; 18(3):221-243. PubMed ID: 33893076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
